A Service Evaluation of Adherence with Antimicrobial Guidelines in the Treatment of Community-Acquired Pneumonia Before and During the SARS-CoV-2 Outbreak
- PMID: 36258797
- PMCID: PMC9559268
- DOI: 10.1007/s42399-022-01311-0
A Service Evaluation of Adherence with Antimicrobial Guidelines in the Treatment of Community-Acquired Pneumonia Before and During the SARS-CoV-2 Outbreak
Abstract
Antimicrobial stewardship is essential to reducing antimicrobial resistance, reducing costs, and, crucially, ensuring good patient care. Community-acquired pneumonia (CAP) is a common medical condition, the symptoms of which show a significant overlap with those of COVID-19. Following the COVID-19 outbreak in Ireland, patients presenting to our hospital with features of a respiratory infection were more commonly reviewed within 24 hours (24h) of admission by an infectious disease (ID) or respiratory specialist. We aimed to assess how the change in service provision, involving frequent specialist reviews of patients admitted with features of CAP during the first wave of the COVID-19 pandemic, affected antimicrobial stewardship and prescribing practices. Patients admitted under general medical teams treated for CAP from March-April 2020 were included. Retrospective data including demographics, CURB-65 score, and antimicrobial therapy were collected, as well as information on whether the patient had undergone specialist review by an ID or respiratory physician. Data were compared to a similar cohort treated for CAP between November 2019 and January 2020, though in this cohort, before the era of COVID-19, none of the patients had undergone specialist review. Seventy-six patients were included from the March-April 2020 cohort, with 77 from November 2019-January 2020 for comparison. An ID or respiratory specialist reviewed 35 patients from the March-April cohort within 24 h of admission. There was a higher rate of appropriate escalation, de-escalation, and continuation of antibiotics among those reviewed. Less than 20% of patients were started on antibiotics in accordance with CAP guidelines on admission, though the antibiotics initiated were frequently deemed appropriate in the clinical setting. Specialist review increases rates of appropriate antimicrobial prescribing and adherence with hospital guidelines in patients with CAP.
Keywords: Antimicrobial stewardship; COVID-19; Community-acquired pneumonia; Service evaluation.
© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of InterestThe authors declare no competing interests.
Similar articles
-
Antibiotic prescribing patterns among patients admitted to an academic teaching hospital for COVID-19 during the first wave of the pandemic in Toronto: A retrospective, controlled study.J Assoc Med Microbiol Infect Dis Can. 2022 Feb 24;7(1):14-22. doi: 10.3138/jammi-2021-0020. eCollection 2022 Mar. J Assoc Med Microbiol Infect Dis Can. 2022. PMID: 36340852 Free PMC article.
-
Antimicrobial therapy of community-acquired pneumonia during stewardship efforts and a coronavirus pandemic: an observational study.BMC Pulm Med. 2022 Oct 14;22(1):379. doi: 10.1186/s12890-022-02178-6. BMC Pulm Med. 2022. PMID: 36242006 Free PMC article.
-
Antimicrobial prescribing and outcomes of community-acquired pneumonia in Australian hospitalized patients: a cross-sectional study.J Int Med Res. 2021 Nov;49(11):3000605211058366. doi: 10.1177/03000605211058366. J Int Med Res. 2021. PMID: 34826375 Free PMC article.
-
Antibiotic stewardship in community-acquired pneumonia.Expert Rev Anti Infect Ther. 2017 Apr;15(4):351-359. doi: 10.1080/14787210.2017.1274232. Epub 2016 Dec 27. Expert Rev Anti Infect Ther. 2017. PMID: 28002979 Review.
-
Application of antimicrobial stewardship to optimise management of community acquired pneumonia.Int J Clin Pract. 2011 Jul;65(7):775-83. doi: 10.1111/j.1742-1241.2011.02704.x. Int J Clin Pract. 2011. PMID: 21676120 Review.
References
-
- Triantafyllidis C, Kapordelis V, Papaetis GS, et al. Guidelines adherence for patients with community acquired pneumonia in a Greek hospital. Eur Rev Med Pharmacol Sci. 2012;16(1):1–9. - PubMed
-
- Delaney F, Jackson A. An audit of empiric antibiotic choice in the inpatient management of community-acquired pneumonia. Ir Med J. 2017;110(4):545. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous